• Mashup Score: 7

    The use of direct oral anticoagulants (DOACs) was associated with a reduction in dementia risk compared to traditional blood thinners – like warfarin – in patients with atrial fibrillation (AFib), particularly in Asians, according to a study published Sept. 5 in JACC: Asia. This benefit may reverse with increased age and necessitates further follow-up study. Khi Yung Fong, et al., conducted a literature review of studies comparing the incidence of dementia between AFib patients treated with warfarin

    Tweet Tweets with this article
    • The use of DOACs was associated with a reduction in dementia risk compared to traditional blood thinners in patients with #AFib, particularly in Asians, according to a study published in #JACCAsia. Learn more: https://t.co/BdFIb0MyTf https://t.co/ZD3OfZ6fjB

  • Mashup Score: 8

    Abstract Transcatheter structural heart intervention (TSHI) has gained popularity over the past decade as a means of cardiac intervention in patients with prohibitive surgical risks. Following the …

    Tweet Tweets with this article
    • #JACCAsia SOTA review highlights role of #EchoFirst transcatheter structural heart interventions available in Asia. 3D #cvEcho, fusion imaging, & ICE methods reviewed. Established interventions & novel approaches discussed. https://t.co/jckWeCinQk #ACCIntl #CardioTwitter https://t.co/sPoFb7nR9I

  • Mashup Score: 0

    Compared with warfarin, direct oral anticoagulants were associated with reduced risk for dementia in patients with atrial fibrillation, particularly those from Asian populations, according to a systematic review and meta-analysis. “Asian patients are more likely to be sensitive to vitamin K antagonism, which puts them at high risk for bleeding events, contributing to dementia development or

    Tweet Tweets with this article
    • According to a new study in #JACCAsia, DOACs were associated with a decreased risk for dementia compared with warfarin in #AFib patients. Read more about the findings in @CardiologyToday: https://t.co/OHJfgDznXb

  • Mashup Score: 7
    JACC: Asia: Vol 3, No 4 - 8 month(s) ago

    JACC: Asia. 2023 Aug, 3 (4) 539–555. Raja Ezman Raja Shariff, Alex Pui-Wai Lee, et. al. JACC: Asia. 2023 Aug, 3 (4) 556–579. JACC: Asia. 2023 Aug, 3 (4) 580–591. Saket Sanghai and Charles A. Henrikson JACC: Asia. 2023 Aug, 3 (4) 592–594. Yukihiro Koretsune, Hiroshi Inoue, et. al. JACC: Asia. 2023 Aug, 3 (4) 595–607. JACC: Asia. 2023 Aug, 3 (4) 608–610. JACC: Asia. 2023 Aug, 3 (4) 611–621. JACC: Asia. 2023 Aug, 3 (4) 622–624. JACC: Asia. 2023 Aug, 3 (4) 625–633. JACC: Asia. 2023 Aug, 3 (4) 634–635. JACC:

    Tweet Tweets with this article
    • Join the #JACC and #JACCAsia EiCs, Drs. Valentin Fuster & Jian'an Wang, for an insightful discussion on the future of Asian cardiology at the #GWICC, JACC: Asia joint session starting now! Stay updated with the latest issue here: https://t.co/CxdJSfvdAT #ACCIntl #CardioTwitter https://t.co/nAtUCdQXMj

  • Mashup Score: 0

    Contact: Katie Glenn, kglenn@acc.org, The use of direct oral anticoagulants (DOACs) was associated with a reduction in dementia risk compared to traditional blood thinners — like warfarin — in atrial fibrillation patients, particularly in Asian patients. According to a study published today in JACC: Asia, this benefit may reverse with increased age and necessitates further follow-up study. “Asian patients are more likely to be sensitive to vitamin K antagonism, which puts them at high risk for bleeding

    Tweet Tweets with this article
    • DOAC use is associated with a reduced dementia risk compared to traditional blood thinners in #AFib patients, particularly in Asian patients. According to a #JACCAsia study, this benefit may reverse with increased age. Read more: https://t.co/b4UzKWtdkx #NOAC https://t.co/H7Bu5EKTzy

  • Mashup Score: 1

    Meeting Type: Live Meetings – International Location: Edsa Shangri-La Manila, Manila, Philippines United by our shared commitment of transforming cardiovascular care, the American College of Cardiology (ACC) and the Philippine Heart Association invite you to join us for an innovative educational experience that will strengthen your everyday practice. ACC Asia 2023 is designed to deliver an engaging forum to critically examine evidence-based strategies as well as contemporary best practices and clinical

    Tweet Tweets with this article
    • Have you explored the #ACCAsia agenda? Check out these can't-be-missed sessions like Women & CV Health; STEMI Care Around the World; Philippine Journal of Cardiology and #JACCAsia & more! There is still time left to save on registration! https://t.co/B6qjct6nVj #ACCIntl https://t.co/sQR79woKc6